Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
LB Pharmaceuticals Inc most recently reported annual revenue of $0, a net loss of $25.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
LB Pharmaceuticals Inc: net profit was positive in 0 of 4 reported years; the most recent year shows a net loss of $25.0M.
Income Statement — 4 Years (USD millions)
Metric
2022
2023
2024
2025
Revenue
$0
$0
$0
$0
Operating Expenses
$3.0M
$11.0M
$65.0M
$30.0M
Operating Profit
−$3.0M
−$11.0M
−$65.0M
−$30.0M
Other Income
−$12.0M
$5.0M
$2.0M
$5.0M
Interest
$2.0M
$5.0M
$0
$0
Depreciation
$0
$0
$0
$0
Profit Before Tax
−$14.0M
−$6.0M
−$63.0M
−$25.0M
Tax rate (%)
-0.0%
-0.0%
0.0%
0.0%
Net Profit
−$14.0M
−$6.0M
−$63.0M
−$25.0M
EPS
−$4.05
−$1.77
−$17.83
−$1.00
Quarterly Results — Last 10 Quarters (USD millions)
Metric
Mar '24
Jun '24
Sep '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Operating Expenses
$17.0M
$27.0M
$16.0M
$6.0M
$6.0M
$5.0M
$14.0M
$22.0M
$54.0M
−$3.0M
Operating Profit
−$17.0M
−$27.0M
−$16.0M
−$6.0M
−$6.0M
−$5.0M
−$14.0M
−$22.0M
−$54.0M
$3.0M
Interest
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Profit Before Tax
−$16.0M
−$28.0M
−$14.0M
−$5.0M
−$5.0M
−$4.0M
−$11.0M
−$19.0M
−$52.0M
−$59.0M
Tax rate (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
-0.0%
0.0%
0.0%
0.0%
Net Profit
−$16.0M
−$28.0M
−$14.0M
−$5.0M
−$5.0M
−$4.0M
−$11.0M
−$19.0M
−$52.0M
−$59.0M
EPS
−$4.56
−$7.82
−$0.63
−$20.21
−$20.21
−$0.14
−$0.45
−$0.67
−$1.71
−$1.79
Over the 4 years reported for LB Pharmaceuticals Inc, borrowings decreased from $24.0M in 2022 to $4.0M in 2025, cash stood at $250.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 44.00 times.
Balance Sheet — 4 Years (USD millions)
Metric
2022
2023
2024
2025
Total Assets
$21.0M
$46.0M
$34.0M
$313.0M
Current Assets
$21.0M
$46.0M
$29.0M
$308.0M
Cash
$21.0M
$15.0M
$23.0M
$250.0M
Inventory
$0
$0
$0
$0
Receivables
$0
$0
$0
$0
Fixed Assets
$0
$0
$4.0M
$4.0M
Capital Work in Progress
$0
$0
$0
$0
Investments
$0
$28.0M
$5.0M
$46.0M
Other Assets
$0
$0
$0
$0
Total Liabilities
$50.0M
$80.0M
$128.0M
$12.0M
Current Liabilities
$0
$3.0M
$8.0M
$7.0M
Borrowings
$24.0M
$0
$4.0M
$4.0M
Other Liabilities
$26.0M
$80.0M
$124.0M
$8.0M
Equity
$0
$0
$0
$0
Reserves
−$29.0M
−$34.0M
−$95.0M
$301.0M
For LB Pharmaceuticals Inc, operating cash flow was positive in 0 of 4 reported years; free cash flow in the latest year was negative at $35.0M; free cash flow was positive in 0 of 4 years.
LB Pharmaceuticals Inc (LBRX) reported annual revenue of $0 in its most recent fiscal year.
What is LB Pharmaceuticals Inc's net profit?
LB Pharmaceuticals Inc (LBRX) reported a net loss of $25.0M in its most recent fiscal year.
What is LBRX EV/EBITDA?
LB Pharmaceuticals Inc's enterprise value to EBITDA (EV/EBITDA) ratio is -11.44. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.
Revenue and earnings of other Biotechnology stocks